Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Strengthening bonds via RyR2 inhibition helps immune suppression
Erienne G. Norton, … , Nicole M. Chapman, Hongbo Chi
Erienne G. Norton, … , Nicole M. Chapman, Hongbo Chi
Published December 15, 2023
Citation Information: J Clin Invest. 2023;133(24):e172986. https://doi.org/10.1172/JCI172986.
View: Text | PDF
Commentary

Strengthening bonds via RyR2 inhibition helps immune suppression

  • Text
  • PDF
Abstract

Foxp3-expressing Tregs employ multiple suppressive mechanisms to curtail conventional T cell (Tconv) responses and establish tissue homeostasis. How Foxp3 coordinates Treg contact–dependent suppressive function is not fully resolved. In this issue of the JCI, Wang and colleagues revealed that Foxp3-mediated inhibition of ryanodine receptor 2 (RyR2) led to strong Treg-DC interactions and enhanced immunosuppression. RyR2 depletion in Tconvs phenocopied this effect and equipped Tconvs with Treg-like suppressive function in multiple inflammatory or autoimmune contexts. This study provides molecular and therapeutic insights underlying how cell-cell contact limits immune reactivity.

Authors

Erienne G. Norton, Nicole M. Chapman, Hongbo Chi

×

Figure 1

RyR2 controls the binding dynamics of Tregs and Tconvs with DCs and its inhibition facilitates immune suppression.

Options: View larger image (or click on image) Download as PowerPoint
RyR2 controls the binding dynamics of Tregs and Tconvs with DCs and its ...
Expression of the sarcoendoplasmic reticulum-localized calcium (Ca2+) release channel component RyR2 is high in conventional CD4+ T cells (Tconvs). RyR2 contributes to high basal Ca2+ oscillations and relatively weak adhesion to DCs, owing to increased m-calpain activation that promotes LFA-1 cleavage and disrupted LFA-1–ICAM-1 interactions. In Tregs, Foxp3 suppresses RyR2 expression, resulting in low basal Ca2+ oscillations and downstream m-calpain activity. Consequently, less LFA-1 is cleaved from the Treg surface, and Tregs strongly adhere to DCs via enhanced LFA-1–ICAM-1 interactions. Pharmacological inhibition using JTV519 or shRNA-mediated targeting of RyR2 in Tconvs phenocopies the contact-dependent immunosuppressive effects of Tregs without causing them to adopt a Treg-like program (e.g., Foxp3 expression). Ultimately, low RyR2 levels increase the interactions between Tregs or Tconvs and DCs, thereby promoting immune suppression. Of note, Tregs display higher suppressive function than RyR2-deficient Tconvs, likely due to their capacity to engage both cell contact–dependent and cell contact–independent mechanisms.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts